Literature DB >> 10206558

Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.

D Doller1, S Chackalamannil, M Czarniecki, R McQuade, V Ruperto.   

Abstract

A parallel synthesis of racemic himbacine analogs was carried out by N-alkylation of various commercially available cyclic amine derivatives with the alkylating agent 4 which bears the tricyclic unit of himbacine. Several of these analogs have potency comparable to that of himbacine, albeit lacking the desired selectivity. Structure-activity relationship studies support the existence of a hydrophobic pocket in the receptor where the piperidine ring of dihydrohimbacine binds.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206558     DOI: 10.1016/s0960-894x(99)00101-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats.

Authors:  Xiu-Li Wang; Hong-Mei Zhang; De-Pei Li; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Physiol       Date:  2006-01-12       Impact factor: 5.182

2.  Differential regulation of primary afferent input to spinal cord by muscarinic receptor subtypes delineated using knockout mice.

Authors:  Shao-Rui Chen; Hong Chen; Wei-Xiu Yuan; Jürgen Wess; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2014-04-02       Impact factor: 5.157

Review 3.  Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events.

Authors:  James E Frampton
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

Review 4.  Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555.

Authors:  Sergio Leonardi; Pierluigi Tricoci; Richard C Becker
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

Review 5.  Antiplatelet therapy: thrombin receptor antagonists.

Authors:  Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Dominick J Angiolillo
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

6.  Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice.

Authors:  Shao-Rui Chen; Hong Chen; Wei-Xiu Yuan; Jürgen Wess; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

Review 7.  Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar.

Authors:  Mohamed Farag; Hiten Patel; Diana A Gorog
Journal:  Drug Des Devel Ther       Date:  2015-07-22       Impact factor: 4.162

Review 8.  Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.

Authors:  Jung Rae Cho; Fabiana Rollini; Francesco Franchi; Elisabetta Ferrante; Dominick J Angiolillo
Journal:  Vasc Health Risk Manag       Date:  2014-04-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.